ANI Pharmaceuticals, Inc. (ANIP)

79.50 -0.44 (-0.55%) USD  |  NASDAQ  |  Apr 22, 15:05
More

ANI Pharmaceuticals Price Target Std Dev

Price Target Std Dev Chart

View Price Target Std Dev for ANIP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price Target Std Dev Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price Target Std Dev Range, Past 5 Years

View Price Target Std Dev Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price Target Std Dev Benchmarks

View Price Target Std Dev Benchmarks
Start Trial
Liquidia Corp. Upgrade
Catalyst Pharmaceuticals, Inc. Upgrade
Indivior Pharmaceuticals, Inc. Upgrade
Replimune Group, Inc. Upgrade
ADMA Biologics, Inc. Upgrade